The sirtuin class of histone deacetylases: Regulation and roles in lipid metabolism

IUBMB Life

Volumn 66, Issue 2, 2014, Pages 89-99

  Fiorino, Erika ^a   Giudici, Marco ^a,b   Ferrari, Alessandra ^a   Mitro, Nico ^a   Caruso, Donatella ^a   De Fabiani, Emma ^a   Crestani, Maurizio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

energy metabolism; lipid metabolism; metabolic regulation; obesity; sirtuins; type 2 diabetes

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7;

ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; CELL FUNCTION; COMPLEX FORMATION; DEGENERATIVE DISEASE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME MODIFICATION; ENZYME STRUCTURE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; LIPID LIVER LEVEL; LIPID METABOLISM; LIVER METABOLISM; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHYLOGENY; PROTEIN PROCESSING; REVIEW; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

ENERGY METABOLISM; LIPID METABOLISM; METABOLIC REGULATION; OBESITY; SIRTUINS; TYPE 2 DIABETES;

ADIPOSE TISSUE; ENERGY METABOLISM; HISTONE DEACETYLASES; HUMANS; LIPID METABOLISM; LIVER; MOLECULAR TARGETED THERAPY; OBESITY; PROTEIN CONFORMATION; SIRTUINS;

EID: 84896393257     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1246     Document Type: Review

References (97)

1. Richards, E. J., and, Elgin, S. C. R., (2002) Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell 108, 489-500.
2. Grunstein, M., (1997) Histone acetylation in chromatin structure and transcription. Nature 389, 349-352.
3. López-Rodas, G., Brosch, G., Georgieva, E. I., Sendra, R., Franco, L., et al. (1993) Histone deacetylase: a key enzyme for the binding of regulatory proteins to chromatin. FEBS Lett. 317, 175-180.
4. de Ruijter, A. J., van Gennip, A. H., Caron, H. N., Kemp, S., and, van Kuilenburg, A. B., (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737-749.
5. Gregoretti, I., Lee, Y.-M., and, Goodson, H. V., (2004) Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J. Mol. Biol. 338, 17-31.
6. Imai, S., Johnson, F. B., Marciniak, R. A., McVey, M., Park, P. U., et al. (2000) Sir2: an NAD-dependent histone deacetylase that connects chromatin silencing, metabolism, and aging. Cold Spring Harbor Symp. Quantit. Biol. 65, 297-302.
7. Liszt, G., Ford, E., Kurtev, M., and, Guarente, L., (2005) Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J. Biol. Chem. 280, 21313-21320.
8. Kaeberlein, M., McVey, M., and, Guarente, L., (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13, 2570-2580.
9. Lin, S.-J., Kaeberlein, M., Andalis, A. A., Sturtz, L. A., Defossez, P.-A., et al. (2002) Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature 418, 344-348.
10. Wang, F., Nguyen, M., Qin, F. X.-F., and, Tong, Q., (2007) SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 6, 505-514.
11. Chen, D., Steele, A. D., Lindquist, S., and, Guarente, L., (2005) Increase in activity during calorie restriction requires Sirt1. Science 310, 1641.
12. Boily, G., Seifert, E. L., Bevilacqua, L., He, X. H., Sabourin, G., et al. (2008) SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS ONE 3, e1759.
13. Guarente, L., (2011) Sirtuins, aging, and medicine. New Engl. J. Med. 364, 2235-2244.
14. Kanfi, Y., Naiman, S., Amir, G., Peshti, V., Zinman, G., et al. (2012) The sirtuin SIRT6 regulates lifespan in male mice. Nature 483, 218-221.
15. Frye, R. A., (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273, 793-798.
16. Tanno, M., Sakamoto, J., Miura, T., Shimamoto, K., and, Horio, Y., (2007) Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J. Biol. Chem. 282, 6823-6832.
17. Vaquero, A., Scher, M. B., Lee, D. H., Sutton, A., Cheng, H.-L., et al. (2006) SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 20, 1256-1261.
18. Lombard, D. B., Alt, F. W., Cheng, H.-L., Bunkenborg, J., Streeper, R. S., et al. (2007) Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 27, 8807-8814.
19. Ford, E., Voit, R., Liszt, G., Magin, C., Grummt, I., et al. (2006) Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20, 1075-1080.
20. Lavu, S., Boss, O., Elliott, P. J., and, Lambert, P. D., (2008) Sirtuins-novel therapeutic targets to treat age-associated diseases. Nat. Rev. Drug Discov. 7, 841-853.
21. Finnin, M. S., Donigian, J. R., and, Pavletich, N. P., (2001) Structure of the histone deacetylase SIRT2. Nat. Struct. Biol. 8, 621-625.
22. Schuetz, A., Min, J., Antoshenko, T., Wang, C.-L., Allali-Hassani, A., et al. (2007) Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin. Structure 15, 377-389.
23. Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., et al. (2011) Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806-809.
24. Pan, M., Yuan, H., Brent, M., Ding, E. C., and, Marmorstein, R., (2012) SIRT1 contains N- and C-terminal regions that potentiate deacetylase activity. J. Biol. Chem. 287, 2468-2476.
25. Pan, P. W., Feldman, J. L., Devries, M. K., Dong, A., Edwards, A. M., et al. (2011) Structure and biochemical functions of SIRT6. J. Biol. Chem. 286, 14575-14587.
26. Barber, M. F., Michishita-Kioi, E., Xi, Y., Tasselli, L., Kioi, M., et al. (2012) SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487, 114-118.
27. Haigis, M. C., Mostoslavsky, R., Haigis, K. M., Fahie, K., Christodoulou, D. C., et al. (2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic β cells. Cell 126, 941-954.
28. Hayashida, S., Arimoto, A., Kuramoto, Y., Kozako, T., Honda, S.-I., et al. (2010) Fasting promotes the expression of SIRT1, an NAD+-dependent protein deacetylase, via activation of PPARα in mice. Mol. Cell. Biochem. 339, 285-292.
29. Noriega, L. G., Feige, J. N., Canto, C., Yamamoto, H., Yu, J., et al. (2011) CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability. EMBO Rep. 12, 1069-1076.
30. Lee, J., Padhye, A., Sharma, A., Song, G., Miao, J., et al. (2010) A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition. J. Biol. Chem. 285, 12604-12611.
31. Rane, S., He, M., Sayed, D., Vashistha, H., Malhotra, A., et al. (2009) Downregulation of MiR-199a derepresses hypoxia-inducible factor-1α and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circul. Res. 104, 879-886.
32. Giralt, A., Hondares, E., Villena, J. A., Ribas, F., Díaz- Delfín, J., et al. (2011) Peroxisome proliferator-activated receptor-γ coactivator-1α controls transcription of the Sirt3 gene, an essential component of the thermogenic brown adipocyte phenotype. J. Biol. Chem. 286, 16958-16966.
33. Sasaki, T., Maier, B., Koclega, K. D., Chruszcz, M., Gluba, W., et al. (2008) Phosphorylation regulates SIRT1 function. PLoS ONE 3, e4020.
34. Nasrin, N., Kaushik, V. K., Fortier, E., Wall, D., Pearson, K. J., et al. (2009) JNK1 Phosphorylates SIRT1 and promotes its enzymatic activity. PLoS ONE 4, e8414.
35. Guo, X., Williams, J. G., Schug, T. T., and, Li, X., (2010) DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1. J. Biol. Chem. 285, 13223-13232.
36. Yang, Y., Fu, W., Chen, J., Olashaw, N., Zhang, X., et al. (2007) SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat. Cell Biol. 9, 1253-1262.
37. Kim, J.-E., Chen, J., and, Lou, Z., (2008) DBC1 is a negative regulator of SIRT1. Nature 451, 583-586.
38. Kim, E.-J., Kho, J.-H., Kang, M.-R., and, Um, S.-J., (2007) Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol. Cell 28, 277-290.
39. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., et al. (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 429, 771-776.
40. Canto, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., et al. (2009) AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056-1060.
41. Chen, D., Bruno, J., Easlon, E., Lin, S.-J., Cheng, H.-L., et al. (2008) Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 22, 1753-1757.
42. Kim, H.-J., Kim, J. H., Noh, S., Hur, H. J., Sung, M. J., et al. (2010) Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J. Prot. Res. 10, 722-731.
43. Szántó, M., Rutkai, I., Hegedus, C., Czikora, Á., Rózsahegyi, M., et al. (2011) Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction. Cardiovasc. Res. 92, 430-438.
44. Chalkiadaki, A., and, Guarente, L., (2012) High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction. Cell Metab. 16, 180-188.
45. Guarente, L., (2006) Sirtuins as potential targets for metabolic syndrome. Nature 444, 868-874.
46. Bordone, L., and, Guarente, L., (2005) Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat. Rev. Mol. Cell Biol. 6, 298-305.
47. Wu, J., Zhang, F., Yan, M., Wu, D., Yu, Q., et al. (2011) WldS enhances insulin transcription and secretion via a SIRT1-dependent pathway and improves glucose homeostasis. Diabetes 60, 3197-3207.
48. Purushotham, A., Xu, Q., and, Li, X., (2012) Systemic SIRT1 insufficiency results in disruption of energy homeostasis and steroid hormone metabolism upon high-fat-diet feeding. FASEB J. 26, 656-667.
49. Banks, A. S., Kon, N., Knight, C., Matsumoto, M., Gutiérrez- Juárez, R., et al. (2008) SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab. 8, 333-341.
50. Qiang, L., Lin, H.V., Kim-Muller, J. Y., Welch, C. L., Gu, W., et al. (2011) Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through creb deacetylation. Cell Metab. 14, 758-767.
51. Hallows, W. C., Yu, W., Smith, B. C., Devires, M. K., Ellinger, J. J., et al. (2011) Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol. Cell 41, 139-149.
52. Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., et al. (2010) SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121-125.
53. Hallows, W. C., Lee, S., and, Denu, J. M., (2006) Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc. Natl. Acad. Sci. USA 103, 10230-10235.
54. Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., et al. (2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 279, 32345-32353.
55. Sanyal, A. J., (2005) Review article: non-alcoholic fatty liver disease and hepatitis C-risk factors and clinical implications. Aliment. Pharmacol. Ther. 22, 48-51.
56. Hou, X., Xu, S., Maitland-Toolan, K. A., Sato, K., Jiang, B., et al. (2008) SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J. Biol. Chem. 283, 20015-20026.
57. Ponugoti, B., Kim, D.-H., Xiao, Z., Smith, Z., Miao, J., et al. (2010) SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J. Biol. Chem. 285, 33959-33970.
58. Xu, F., Gao, Z., Zhang, J., Rivera, C. A., Yin, J., et al. (2010) Lack of SIRT1 (mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammation. Endocrinology 151, 2504-2514.
59. Li, X., Zhang, S., Blander, G., Tse, J. G., Krieger, M., et al. (2007) SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol. Cell 28, 91-106.
60. Purushotham, A., Schug, T. T., Xu, Q., Surapureddi, S., Guo, X., et al. (2009) Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 9, 327-338.
61. Kemper, J. K., Xiao, Z., Ponugoti, B., Miao, J., Fang, S., et al. (2009) FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab. 10, 392-404.
62. Purushotham, A., Xu, Q., Lu, J., Foley, J. F., Yan, X., et al. (2012) Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1α/Farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice. Mol. Cell. Biol. 32, 1226-1236.
63. You, M., Cao, Q., Liang, X., Ajmo, J. M., and, Ness, G. C., (2008) Mammalian sirtuin 1 is involved in the protective action of dietary saturated fat against alcoholic fatty liver in mice. J. Nutr. 138, 497-501.
64. Yin, H., Hu, M., Zhang, R., Shen, Z., Flatow, L., et al. (2012) MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1. J. Biol. Chem. 287, 9817-9826.
65. Bordone, L., Cohen, D., Robinson, A., Motta, M. C., Van Veen, E., et al. (2007) SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 6, 759-767.
66. Pfluger, P. T., Herranz, D., Velasco-Miguel, S., Serrano, M., and, Tschöp, M. H., (2008) Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. USA 105, 9793-9798.
67. Shi, T., Fan, G. Q., and, Xiao, S. D., (2010) SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells. J. Dig. Dis. 11, 55-62.
68. Shimazu, T., Hirschey, M. D., Hua, L., Dittenhafer-Reed, K. E., Schwer, B., et al. (2010) SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 12, 654-661.
69. Kendrick, A. A., Choudhury, M., Rahman, S. M., McCurdy, C. E., Friederich, M., et al. (2011) Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem. J. 433, 505-514.
70. Nasrin, N., Wu, X., Fortier, E., Feng, Y., Bare', O. C., et al. (2010) SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J. Biol. Chem. 285, 31995-32002.
71. Kim, H.-S., Xiao, C., Wang, R.-H., Lahusen, T., Xu, X., et al. (2010) Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab. 12, 224-236.
72. Takemori, K., Kimura, T., Shirasaka, N., Inoue, T., Masuno, K., et al. (2011) Food restriction improves glucose and lipid metabolism through Sirt1 expression: a study using a new rat model with obesity and severe hypertension. Life Sci. 88, 1088-1094.
73. Jin, Q., Zhang, F., Yan, T., Liu, Z., Wang, C., et al. (2010) C/EBPα regulates SIRT1 expression during adipogenesis. Cell Res. 20, 470-479.
74. Chakrabarti, P., English, T., Karki, S., Qiang, L., Tao, R., et al. (2011) SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL. J. Lipid Res. 52, 1693-1701.
75. Gillum, M. P., Kotas, M. E., Erion, D. M., Kursawe, R., Chatterjee, P., et al. (2011) SirT1 regulates adipose tissue inflammation. Diabetes 60, 3235-3245.
76. Qiang, L., Wang, L., Kon, N., Zhao, W., Lee, S., et al. (2012) Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell 150, 620-632.
77. Shi, T., Wang, F., Stieren, E., and, Tong, Q., (2005) SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J. Biol. Chem. 280, 13560-13567.
78. Jing, E., Gesta, S., and, Kahn, C. R., (2007) SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab. 6, 105-114.
79. Wang, F., and, Tong, Q., (2009) SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARγ. Mol. Biol. Cell 20, 801-808.
80. Çakir, I., Perello, M., Lansari, O., Messier, N. J., Vaslet, C. A., et al. (2009) Hypothalamic Sirt1 regulates food intake in a rodent model system. PLoS ONE 4, e8322.
81. Ramadori, G., Fujikawa, T., Fukuda, M., Anderson, J., Morgan, D. A., et al. (2010) SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity. Cell Metab. 12, 78-87.
82. Wu, D., Qiu, Y., Gao, X., Yuan, X.-B., and, Zhai, Q., (2011) Overexpression of SIRT1 in mouse forebrain impairs lipid/glucose metabolism and motor function. PLoS ONE 6, e21759.
83. Gerhart-Hines, Z., Rodgers, J. T., Bare, O., Lerin, C., Kim, S.-H., et al. (2007) Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α. EMBO J. 26, 1913-1923.
84. Amat, R., Solanes, G., Giralt, M., and, Villarroya, F., (2007) SIRT1 is involved in glucocorticoid-mediated control of uncoupling protein-3 gene transcription. J. Biol. Chem. 282, 34066-34076.
85. Defour, A., Dessalle, K., Castro Perez, A., Poyot, T., Castells, J., et al. (2012) Sirtuin 1 regulates SREBP-1c expression in a LXR-dependent manner in skeletal muscle. PLoS ONE 7, e43490.
86. Palacios, O., Carmona, J., Michan, S., Chen, K., Manabe, Y., et al. (2009) Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1α in skeletal muscle. Ageing 1, 771-783.
87. Peeters, A., Beckers, S., Verrijken, A., Mertens, I., Roevens, P., et al. (2008) Association of SIRT1 gene variation with visceral obesity. Hum. Genet. 124, 431-436.
88. Figarska, S. M., Vonk, J. M., and, Boezen, H. M., (2013) SIRT1 polymorphism, long-term survival and glucose tolerance in the general population. PLoS ONE 8, e58636.
89. Zillikens, M. C., van Meurs, J. B. J., Rivadeneira, F., Amin, N., Hofman, A., et al. (2009) SIRT1 genetic variation is related to BMI and risk of obesity. Diabetes 58, 2828-2834.
90. Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196.
91. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342.
92. Um, J.-H., Park, S.-J., Kang, H., Yang, S., Foretz, M., et al. (2010) AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59, 554-563.
93. Villalba, J. M., and, Alcaín, F.J., (2012) Sirtuin activators and inhibitors. BioFactors 38, 349-359.
94. Yamazaki, Y., Usui, I., Kanatani, Y., Matsuya, Y., Tsuneyama, K., et al. (2009) Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. Am. J. Physiol. Endocrinol. Metab. 297, E1179-E1186.
95. Feige, J. N., Lagouge, M., Canto, C., Strehle, A., Houten, S. M., et al. (2008) Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 8, 347-358.
96. Audrito, V., Vaisitti, T., Rossi, D., Gottardi, D., D'Arena, G., et al. (2011) Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Cancer Res. 71, 4473-4483.
97. Mellini, P., Kokkola, T., Suuronen, T., Salo, H. S., Tolvanen, L., et al. (2013) Screen of pseudopeptidic inhibitors of human sirtuins 1-3: two lead compounds with antiproliferative effects in cancer cells. J. Med. Chem. 56, 6681-6695.